Metformin, vildagliptin
Sold as Galvus met, Jalramet, Vysov met, Galtin plus, Metgulvatin, Xyvilin co, Zomvil co, Vilcomet, Vidamace plus, Vileptin co, Vildagliptin/metformin sun pharma, Vildaglymin, Viglymak plus, Vidiabmet, Avilmet, Diamvil, Vildamet, Vilomet, Dagfotin
Combination product
This product contains more than one active ingredient, so it has no single molecular structure.
Background
Registration
- Applicants
- 12
- Registrations
- 35
- Schedule source
- Consolidated Schedules 06 July 2026
Applicants and registrations
| Applicant | Brands | Dosages | Registrations | Schedule | Leaflets |
|---|---|---|---|---|---|
| Novartis South Africa (Pty) Ltd | Galvus met, Jalramet | 000 mg 50/1, 50 mg/850 mg, 50 mg/1000 mg, 50/850 mg | 431055, 431056, 480729, 480730 | S3 | None |
| Sandoz South Africa (Pty) LtdCancelled | Vysov met | 000 mg 50/1, 50/850 mg | 480731, 480732 | S3 | None |
| Teva Pharmaceuticals (Pty) LtdCancelled | Galtin plus | 850/ 50, 1000/ 50 | 520853, 520854 | S3 | None |
| Pharmacare limited û woodmead | Metgulvatin | 850/50, 1000/50 | 530098, 530099 | S3 | None |
| Trinity Pharma (Pty) Ltd | Xyvilin co, Zomvil co, Vilcomet | 50/850 | 530255, 530257.255, 530259.255 | S3 | None |
| Pharma Dynamics (Pty) Ltd | Vidamace plus | 50/1000 mg | 561180, 561181 | S3 | None |
| Ranbaxy (SA) (Pty) Ltd | Vileptin co, Vildagliptin/metformin sun pharma | 50/850, 50/1 000 | 570060, 570061, 570062.060, 570063.061 | S3 | None |
| Macleods Pharmaceuticals SA (Pty) Ltd | Vildaglymin, Viglymak plus | 50/850, 50/1000 | 570366, 570367, 570368.366, 570369.367 | S3 | None |
| Pharma-q (Pty) Ltd | Vidiabmet | 50/850, 50/1 000 | 590045, 590046 | S3 | None |
| Accord Healthcare (Pty) Ltd | Avilmet, Diamvil | 50 mg/850 mg, 50 mg/1000 mg, 50 mg 000 mg /1 | 590248, 590249, 590250.248, 590251.249 | S3 | None |
| Innovata pharmaceuticals | Vildamet | 50/850, 50/1 000 | 590253, 590254 | S3 | None |
| Hetero Drugs South Africa (Pty) Ltd | Vilomet, Dagfotin | 50/850, 50 mg, 850 mg, 1000 mg | 590341, 590342, 590343.341, 590344.342 | S3 | PIPIL |
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Galvus met 50 mg/850 MG EACH TABLET CONTAINS: VILDAGLIPTIN 50,0 mg METFORMIN HYDROCHLORIDE 850,0 mg | 50 mg/850 mg | 43105543/21.2/1055 | Registered | S3 | None |
| Galvus met 50 mg/1000 MG EACH TABLET CONTAINS: VILDAGLIPTIN 50,0 mg METFORMIN HYDROCHLORIDE 1000,0 mg | 50 mg/1000 mg | 43105643/21.2/1056 | Registered | S3 | None |
| Jalramet 50/850 MG EACH TABLET CONTAINS: VILDAGLIPTIN 50,0 mg ,METFORMIN HYDROCHLORIDE 850,0 mg | 50/850 mg | 48072948/21.2/0729 | Registered | S3 | None |
| Jalramet 50/1 000 MG EACH TABLET CONTAINS: VILDAGLIPTIN 50,0 mg METFORMIN HYDROCHLORIDE 1000,0 mg | 000 mg 50/1 | 48073048/21.2/0730 | Registered | S3 | None |
| Vysov met 50/850 MG EACH TABLET CONTAINS METFORMIN HYDROCHLORIDE 850,0 mgVILDAGLIPTIN 50,0 mg | 50/850 mg | 48073148/21.2/0731 | Cancelled | S3 | None |
| Vysov met 50/1 000 MG EACH TABLET CONTAINS METFORMIN HYDROCHLORIDE 1 000,0 mgVILDAGLIPTIN 50,0 mg | 000 mg 50/1 | 48073248/21.2/0732 | Cancelled | S3 | None |
| Galtin plus 1000/ 50 EACH TABLET CONTAINS: METFORMIN HCl 1000,0 mg VILDAGLIPTIN 50,0 mg | 1000/ 50 | 52085352/21.2/0853 | Cancelled | S3 | None |
| Galtin plus 850/ 50 EACH TABLET CONTAINS: METFORMIN HCl 850,0 mg VILDAGLIPTIN 50,0 mg | 850/ 50 | 52085452/21.2/0854 | Cancelled | S3 | None |
| Metgulvatin 850/50 EACH TABLET CONTAINS: METFORMIN HYDROCHLORIDE 850,0 mg VILDAGLIPTIN 50,0 mg | 850/50 | 53009853/21.2/0098 | Registered | S3 | None |
| Metgulvatin 1000/50 EACH TABLET CONTAINS: METFORMIN HYDROCHLORIDE 1000,0 mg VILDAGLIPTIN 50,0 mg | 1000/50 | 53009953/21.2/0099 | Registered | S3 | None |
| Xyvilin co 50/850 EACH TABLET CONTAINS: VILDAGLIPTIN 50,0 mg METFORMIN HYDROCHLORIDE 850,0 mg | 50/850 | 53025553/21.2/0255 | Registered | S3 | None |
| Zomvil co 50/850 EACH TABLET CONTAINS: VILDAGLIPTIN 50,0 mg METFORMIN HYDROCHLORIDE 850,0 mg | 50/850 | 530257.25553/21.2/0257.255 | Registered | S3 | None |
| Vilcomet 50/850 EACH TABLET CONTAINS: VILDAGLIPTIN 50,0 mg METFORMIN HYDROCHLORIDE 850,0 mg | 50/850 | 530259.25553/21.2/0259.255 | Registered | S3 | None |
| Vidamace plus Each Tablet contains: Vildagliptin 50,0 mg, Metformin Hydrochloride 850,0 mg | Not listed | 56118056/21.2/1180 | Registered | S3 | None |
| Vidamace plus 50/1000 MG Each Tablet contains: Vildagliptin 50,0 mg, Metformin Hydrochloride 1000,0 mg | 50/1000 mg | 56118156/21.2/1181 | Registered | S3 | None |
| Vileptin co 50/850 EACH TABLET CONTAINS VILDAGLIPTIN 50,0 mg METFORMIN HYDROCHLORIDE 850 mg | 50/850 | 57006057/21.2/0060 | Registered | S3 | None |
| Vileptin co 50/1 000 EACH TABLET CONTAINS VILDAGLIPTIN 50,0 mg METFORMIN HYDROCHLORIDE 1 000 mg | 50/1 000 | 57006157/21.2/00061 | Registered | S3 | None |
| Vildagliptin/metformin 50/850 sun pharma EACH TABLET CONTAINS VILDAGLIPTIN 50,0 mg METFORMIN HYDROCHLORIDE 850 mg | 50/850 | 570062.06057/21.2/0062.060 | Registered | S3 | None |
| Vildagliptin/metformin 50/1 000 sun pharma EACH TABLET CONTAINS VILDAGLIPTIN 50,0 mg METFORMIN HYDROCHLORIDE 1 000 mg | 50/1 000 | 570063.06157/21.2/0063.061 | Registered | S3 | None |
| Vildaglymin 50/850 Each Tablet contains: Vildagliptin 50,0 mg, Metformin Hydrochloride 850,0 mg | 50/850 | 57036657/21.2/0366 | Registered | S3 | None |
| Vildaglymin 50/1000 Each Tablet contains: Vildagliptin 50,0 mg, Metformin Hydrochloride 1000,0 mg | 50/1000 | 57036757/21.2/0367 | Registered | S3 | None |
| Viglymak plus 50/850 Each Tablet contains: Vildagliptin 50,0 mg, Metformin Hydrochloride 850,0 mg | 50/850 | 570368.36657/21.2/0368.366 | Registered | S3 | None |
| Viglymak plus 50/1000 Each Tablet contains: Vildagliptin 50,0 mg, Metformin Hydrochloride 1000,0 mg | 50/1000 | 570369.36757/21.2/0369.367 | Registered | S3 | None |
| Vidiabmet 50/850 EACH TABLET CONTAINS: VILDAGLIPTIN 50,0 mg METFORMIN HYDROCHLORIDE 850,0 mg | 50/850 | 59004559/21.2/0045 | Registered | S3 | None |
| Vidiabmet 50/1 000 EACH TABLET CONTAINS: VILDAGLIPTIN 50,0 mg METFORMIN HYDROCHLORIDE 1 000,0 mg | 50/1 000 | 59004659/21.2/0046 | Registered | S3 | None |
| Avilmet 50 mg/850 MG EACH TABLET CONTAINS: VILDAGLIPTIN 50,0 mg METFORMIN HYDROCHLORIDE 850,0 mg | 50 mg/850 mg | 59024859/21.2/0248 | Registered | S3 | None |
| Avilmet 50 mg/1000 MG EACH TABLET CONTAINS: VILDAGLIPTIN 50,0 mg METFORMIN HYDROCHLORIDE 1 000,0 mg | 50 mg/1000 mg | 59024959/21.2/0249 | Registered | S3 | None |
| Diamvil 50 mg/850 MG EACH TABLET CONTAINS: VILDAGLIPTIN 50,0 mg METFORMIN HYDROCHLORIDE 850,0 mg | 50 mg/850 mg | 590250.24859/21.2/0250.248 | Registered | S3 | None |
| Diamvil 50 mg/1 000 MG EACH TABLET CONTAINS: VILDAGLIPTIN 50,0 mg METFORMIN HYDROCHLORIDE 1 000,0 mg | 50 mg 000 mg /1 | 590251.24959/21.2/0251.249 | Registered | S3 | None |
| Vildamet 50/850 EACH TABLET CONTAINS VILDAGLIPTIN 50,0 mg METFORMIN HYDROCHLORIDE 850,0 mg | 50/850 | 59025359/21.2/0253 | Registered | S3 | None |
| Vildamet 50/1 000 EACH TABLET CONTAINS VILDAGLIPTIN 50,0 mg and METFORMIN HYDROCHLORIDE 1 000,0 mg | 50/1 000 | 59025459/21.2/0254 | Registered | S3 | None |
| Vilomet 50/850 EACH TABLET CONTAINS: VILDAGLIPTIN 50,0 mg METFORMIN HYDROCHLORIDE 850,0 mg | 50/850Film-coated tablets | 59034159/21.2/0341Approved 27 January 2026 | Registered | S3 | PIPIL |
| Vilomet 50/1 000 EACH TABLET CONTAINS: VILDAGLIPTIN 50,0 mg METFORMIN HYDROCHLORIDE 1 000,0 mg | 50 mg, 850 mg, 1000 mgFilm-coated tablets | 59034259/21.2/0342Approved 27 January 2026 | Registered | S3 | PIPIL |
| Dagfotin 50/850 EACH TABLET CONTAINS: VILDAGLIPTIN 50,0 mg METFORMIN HYDROCHLORIDE 850,0 mg | 50/850Film-coated tablets | 590343.34159/21.2/0343.341Approved 27 January 2026 | Registered | S3 | PIPIL |
| Dagfotin 50/1 000 EACH TABLET CONTAINS: VILDAGLIPTIN 50,0 mg METFORMIN HYDROCHLORIDE 1 000,0 mg | 50 mg, 850 mg, 1000 mgFilm-coated tablets | 590344.34259/21.2/0344.342Approved 27 January 2026 | Registered | S3 | PIPIL |
Regulatory status
Where S3 sits on the scale
Needs a doctor's prescription, dispensed by a pharmacist.
Schedule 3 medicines can only be sold on a prescription from an authorised prescriber, such as a doctor or dentist. A pharmacist dispenses the medicine once they have the written prescription, or a verbal instruction from a prescriber they know. Its price, name, pack size and strength can still be told to the public, as long as nothing links it to what it treats.
Schedule S3, matched to the Consolidated Schedules by ingredient, confidence medium.
Who may supply: A pharmacist dispensing against a written or verbal prescription from an authorised prescriber; a veterinarian, who may also prescribe, compound or dispense it directly; a medical practitioner or dentist, who may prescribe it and may compound or dispense it directly only if licensed under section 22C(1)(a); manufacturers and wholesalers may supply people who may lawfully possess it; and, for animal treatment, a person practising a para-veterinary profession, on a veterinarian's written or verbal instruction.
Consolidated Schedules listings for Vildagliptin, metformin hydrochloride
S3: Metformin
Consolidated Schedules 06 July 2026, line 3938
S3: Vildagliptin
Consolidated Schedules 06 July 2026, line 4386
Pharmacological class: Oral hypoglycaemics. (class 21.2)
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
SAHPRA documents
Schedule Verification
Vilomet 50/850, Hetero Drugs South Africa (Pty) Ltd is scheduled S3 in its official SAHPRA documents, read with 90% confidence.
These documents are provided by SAHPRA for informational purposes. Always consult with a healthcare professional for medical advice.